Shareholders might have noticed that Cencora, Inc. (NYSE:COR) filed its quarterly result this time last week. The early response was not positive, with shares down 3.1% to US$283 in the past week.

Healthcare distributor Cencora (NYSE:COR) will be reporting earnings tomorrow before the bell. Here’s what to expect. Cencora beat analysts’ revenue expectations by 5.2% last quarter, reporting ...

Walgreens Boots settles prepaid share contracts early, generating $300M in proceeds. WBA reduces Cencora stake from 10% to 6% to support debt reduction. Get access to the leaderboards pointing to ...

Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...

Cencora has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale ...

Cencora, Inc. COR recently completed the previously announced acquisition of Retina Consultants of America (“RCA”), a leading management services organization (“MSO”) of retina specialists ...

CONSHOHOCKEN, Pa. - Cencora, Inc. (NYSE: COR), a global pharmaceutical solutions organization with a market capitalization of $43.4 billion, has completed the acquisition of Retina Consultants of ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the completion of its previously announced acquisition of Retina Consultants of America (“RCA”), a leading ...

Forbes contributors publish independent expert analyses and insights. Global pharmaceutical company Cencora, Inc. recently announced the appointment of Pawan Verma as Executive Vice President and ...